Flavokawain B (FKB), a natural kava chalcone, shows potent antitumor activity in various types of cancer, although the mechanism of action remains unclear. In this study, we report that FKB has profound effects on the metabolic state of human thyroid cancer (TCa) cells, leading to high autophagy flux through upregulation of AMP-activated protein kinase, which in turn inhibits mTOR and activates Beclin-1 in TCa cells. We further report that the autophagy induced by FKB plays a prosurvival role in TCa cells both in vitro and in vivo. In conclusion, our findings provide evidence that combination treatment with FKB and pharmacological autophagy inhibitors will be a potential therapeutic strategy for the treatment of TCa. antitumor effect of FKB is mainly attributed to induction of apoptotic cell death characterized by nuclear fragmentation, DNA damage, poly (ADP-ribose) polymerase (PARP) cleavage, and cytochrome C release followed by caspase-3 and caspase-9 activation.
Previous studies have shown that treatment with autophagy inhibitors such as bafilomycin A1 and chloroquine (CQ) potentiates the effects of several cancer treatments. 12, 13 These studies have led to the initiation of multiple clinical trials combining chemotherapeutic agents and autophagy inhibitors for various cancer types. 14 However, it has also been proposed that autophagy stimulates a prodeath signal pathway that could function as a backup when apoptosis is disabled. 15, 16 Thus, the specific role of autophagy seems to be highly cell-type-dependent and context-dependent. Previous studies have reported that autophagy was regulated by diverse signaling pathways, such as endoplasmic reticulum stress, energy sensor AMP-activated protein kinase (AMPK), mTOR kinase, and those controlled by class I PI3k-AKT signaling. 17, 18 In this study, we showed that FKB activates the AMPK pathway, which in turn inhibits mTOR and activates Beclin-1, thus leading to high autophagy flux. Furthermore, we found that autophagy induced by FKB plays a cytoprotective role in TCa cells both in vitro and in vivo. Based on our results, FKB is a potential therapeutic agent in the treatment of human TCa and combination therapy with FKB and autophagy inhibitors might represent a promising avenue with higher efficacy for TCa patients. Hyclone, GE Healthcare Life Sciences) in a humidified incubator with 5% CO 2 at 37°C.
| MATERIALS AND METHODS

| Cell lines and cultures
| Cell viability and proliferation assays
Cell viability was assessed with the CCK-8 (CK04-500; Dojindo, Kumamoto, Japan). Thyroid cancer cells (1.0 × 10 4 cells/well) were seeded into 96-well plates. After the desired treatment, cells were incubated for an additional 4 h at 37°C with 10 μL CCK-8 in 100 μL serum-free DMEM. The absorbance at 450 nm was measured using a microplate reader (Bio-Rad, Hercules, CA USA). Proliferation was assessed using the EdU incorporation assay according to the manufacturer's protocol (C103103; Ribobio, Guangzhou, China). The percentage of labeled cells (ratio: EdU+/DAPI+ × 100%) was determined using images taken for four random fields per sample under fluorescence.
| Flow cytometric analysis of apoptosis
The TCa cells were harvested and resuspended in a binding buffer.
Cells were then stained with annexin V-FITC (BD Biosciences, San
Jose, CA, USA) according to the manufacturer's instructions. Cells were analyzed by a flow cytometry (NovoCyte; ACEA, San Diego, CA, USA), and the data were analyzed with FlowJo Software (Tree Star, Ashland, OR, USA).
| Cell migration and invasion assays
Cell migration was assessed in wound healing assays. A cell-free gap was generated by scratching the cell monolayer with a 200-μL pipette tip, and images used for analysis were captured under a light microscope at 0 and 12 h. Cell invasion was examined using the 
| Small interfering RNAs
Gene-specific siRNAs and one non-targeting siRNA were synthesized from GenePharma. ATG5#1 and ATG5#2 siRNAs target the sequences 5′-CCT TTG GCC TAA GAA GAA A-3′ and 5′-CAT CTG AGC TAC CCG GAT A-3′, respectively; ATG7 #1 and ATG7
#2 siRNAs target the sequences 5′-GGA GTC ACA GCT CTT CCT T-3′ and 5′-CAG CTA TTG GAA CAC TGT A-3′, respectively;
Beclin1 siRNA targets the sequences 5′-GGA AGC TCA GTA TCA-GAGA-3′; and AMPKα1 siRNA targets the sequence 5′-GAGGA-GAGC TAT TTG ATT A-3′. The non-targeting control siRNA targets the sequence 5′-UUCUCCGAACGUGUCACGUTT-3′. 
| Animal studies
| Cell apoptosis assay and immunohistochemistry
The TUNEL assay was carried out using the In Situ Cell Death Detection Kit, TMR Green (Roche, Basel, Switzerland) following the manufacturer's recommendations. After labeling, the slides were counterstained with DAPI and visualized under a fluorescence microscopy. For immunohistochemistry, heat-induced epitope retrieval was undertaken with a microwave in 10 mmol/L citric acid buffer.
The samples were incubated at 4°C overnight with the primary antibody (rabbit anti-Ki67, 1:200 dilution; Cell Signaling Technology).
Next, the sections were incubated with HRP-linked goat anti-rabbit, followed by reaction with diaminobenzene and counterstaining with
Mayer's hematoxylin.
| Statistical analysis
Three independent experiments were carried out, and results are expressed as the mean ± SD. Data were compared using paired ttests in GraphPad Prism 5 software (San Diego, CA, USA), and Pvalues determined from different comparisons are indicated as:
*P < 0.05, **P < 0.01, ***P < 0.001.
| RESULTS
| Flavokawain B inhibits growth of TCa cells
To begin to determine whether FKB might be effective against TCa cells, FKB treatment was first evaluated in three human TCa cell lines, ARO, WRO, and TPC-1 cells in vitro, using the CCK-8 assay.
We found that FKB effectively decreased the proliferation of the indicated cells in a dose-and time-dependent manner (Fig. 1A ).
An EdU incorporation assay was used to further evaluate proliferation of TCa cell lines in the presence of FKB. As shown in Figure 1 (B,C), there was a statistically significant decrease in proliferation for three cell lines at 24 h after exposure to FKB.
Increasing FKB concentrations were more effective, with only partial EdU-positive cells at 6 μg/mL after 24 h (~5%; P < 0.01).
Flavokawain B induces apoptosis in a variety of cancer cells.
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We therefore determined whether FKB also induces apoptosis of stages with FKB at 24 h (Fig. 1D ). After treatment with indicated concentrations of FKB for 24 h (Fig. S1 ), cleaved PARP and cleaved caspase-3 levels were increased in ARO, WRO, and TPC-1 cells in a dose-dependent manner.
| Flavokawain B attenuates migration and invasion of TCa cells
To determine whether FKB inhibited migration and invasive proper- and TPC-1 cells (Fig. 2A,B) . Counts of cells that had migrated through the membrane at 24 h were decreased by~80% after exposure to 6 μg/mL FKB for all three cell lines (Fig. 2C) . The rearrangement of the cytoskeleton is an important characteristic of migrating and invading cancer cells. 22 Untreated TCa cells were characterized by more organized F-actin filaments compared to FKB-treated cells (Fig. 2D ).
| Flavokawain B induces mitochondrial dysfunction in TCa cells
Invasion is a high energy and nutrient-consuming process in cancer cells. 23 To begin to understand whether FKB might interfere with cancer cell metabolism, ATP synthesis levels were first examined in FKB-treated TCa cells. In ARO, WRO, and TPC-1 cells, ATP levels were moderately decreased after treatment with FKB at 4 and 6 μg/ mL concentrations at 24 h (P < 0.05; Fig. 3A ). The JC-1 probe is an indicator of Δψm, which emits red fluorescence upon formation of Jaggregates under high Δψm conditions and green fluorescence from J-monomers under low Δψm conditions. Thus, the conversion between red and green fluorescence directly reflects changes in
Δψm. 24 In ARO, WRO, and TPC-1 cells, green fluorescence increased under treatment with 6 μg/mL FKB (Fig. 3B) , as indicated by the decrease in red/green fluorescence ratios (Fig. S2) . The results
showed that mitochondrial elements became significantly fragmented and unconnected after exposure to 6 μg/mL FKB for 24 h when compared with those in control cells (P < 0.01; Fig. 3C,D) .
| Flavokawain B induces autophagy in TCa cells
Transmission electron microscopy analysis clearly indicated increased production of autophagosomes after 6 μg/mL FKB treatment for 24 h (Fig. 4A) . The percentage of GFP-LC3-positive puncta increased after treatment with 6 μg/mL FKB for 24 h (Fig. 4B) . We then examined the protein level of LC3B-II and p62 in FKB-treated TCa cells.
After 6 μg/mL FKB treatment for the indicated time (Fig. 4C ), or after treatment with the indicated concentration of FKB for 24 h (Fig. 4D) , LC3B-II levels were increased in ARO, WRO, and TPC-1 cells both dose-and time-dependently. Consistent with this, the p62 level decreased in similar manners.
As shown in Figure 5(A,B) , knockdown of ATG5 or ATG7 by siRNA decreased FKB-induced LC3B-II formation in WRO cells. Furthermore, co-incubation with FKB and 3-methyladenine (3-MA) (10 mmol/L), which blocks the upstream steps of autophagy, reduced FKB-induced LC3B-II formation in WRO cells (Fig. 5C ). In contrast, co-incubation with FKB and CQ (3 μmol/L), which blocks the downstream steps of autophagy, increased FKB-induced LC3B accumulation (Fig. 5D ). As shown in Figure 5 (E,G), knockdown of ATG5 and ATG7 decreased FKB-induced LC3B puncta formation (P < 0.01). 3-Methyladenine reduced FKB-induced LC3B puncta formation (P < 0.01), whereas CQ increased FKB-induced LC3B accumulation (P < 0.05; Fig. 5F ,G).
| Flavokawain induces autophagy by inhibiting mTOR and activating Beclin-1 in TCa cells
Mammalian target of rapamycin acts as a key negative regulator of autophagy. 25 In our experiments, we observed that FKB dephosphorylated mTOR in a dose-dependent manner in three TCa cell lines (Fig. 6A) . Autophagy is strictly regulated by a series of ATGs, among which Beclin-1 is essential for initiation of autophagy. 26, 27 It has been reported that Beclin-1 could be directly phosphorylated at Ser93 and Ser96 sites by AMPK in response to glucose starvation. 28 In our experiments, we found that FKB treatment increased the level of p-Beclin-1 Ser93 in three TCa cells. Knockdown of Beclin-1 reduced the FKB-induced LC3B puncta formation (Fig. 6B,C) and enhancement of LC3B-II levels (Fig. 6D ).
| Flavokawain induces autophagy by activating AMPK in TCa cells
AMP-activated protein kinase is activated by alterations in the cellular energy hemostasis. 29 As shown in Figure 7 (Fig. 7B,C) and LC3B puncta formation (Fig. 7D) , and thus further established AMPK as a molecular target for FKB-induced autophagy. We also found that inhibition of AMPK increased the levels of p-mTOR Ser2448, followed by decreased levels of p-Beclin-1 Ser93 in the presence of FKB (Fig. 7B,C) .
| Flavokawain induces cytoprotective autophagy in TCa cells both in vitro and in vivo
Autophagy plays dual roles in cell survival and cell death. 30 The showed that FKB monotherapy significantly reduced tumor growth ( Fig. 8C-E) . Although no statistically significant differences were found between the CQ and control group, treatment with FKB and CQ significantly reduced the tumor volume and tumor weight, compared to vehicle treatment and FKB treatment ( Fig. 8C-E ).
There was no significant body weight loss in FKB or combination treatment groups compared to the control group (Fig. 8F) . Finally, a pronounced increase in apoptosis (TUNEL) was noted in combined treatment xenografts (Figs. 8G,S4A ). The marker for autophagy, LC3B, was increased in tumor cells (Fig. S4B,C) , whereas Ki67, a marker for proliferation, was decreased (Figs. 8G,S4D ) from animals treated with FKB + CQ. from lentiviruses were treated with 6 μg/mL FKB for 24 h. Percentages of cells with more than four GFP-LC3B dots were quantified. (C) Levels of protein expression were analyzed by Western blot using antibodies against LC3B, p62, and GAPDH in ARO, WRO, and TPC-1 cells treated with 6 μg/mL FKB for the indicated times. The number under each band represents the fold change of band intensity relative to control group. The fold change of LC3B only refers to LC3BII. (D) Levels of protein expression were analyzed by Western blot using antibodies against LC3B, p62, and GAPDH in ARO, WRO, and TPC-1 cells treated with the indicated concentration of FKB for 24 h. All data are expressed as the mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 F I G U R E 5 Flavokawain (FKB) induces autophagic flux in thyroid cancer cells. (A,B) ARO, WRO, and TPC-1 cells were transfected with ATG5 or ATG7 siRNAs for 24 h, and treated with 6 μg/mL FKB or DMSO for another 24 h. The samples were subjected to Western blot analysis. Levels of protein expression were analyzed by Western blot using antibodies against ATG5, ATG7, LC3B, and GAPDH. (C,D) ARO, WRO, and TPC-1 cells were pretreated with 3-methyladenine (3-MA) (10 mmol/L) or chloroquine (CQ) (3 μmol/L) for 1 h, and co-incubated with 6 μg/mL FKB or DMSO for another 24 h. Levels of protein expression were analyzed by Western blot using antibodies against LC3B and GAPDH. (E) WRO cells stably transfected with GFP-LC3B were further transfected with ATG5 or ATG7 siRNAs, then treated with 6 μg/mL FKB or DMSO for another 24 h. Cells were then subjected to a fluorescence microscopy. (F) WRO cells stably transfected with GFP-LC3B were cotreated with autophagy inhibitors and FKB as mentioned above, then examined by a fluorescence microscopy. (G) Percentages of cells with more than four GFP-LC3B dots were quantified. All data are expressed as the mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 F I G U R E 6 Flavokawain (FKB) induces autophagy by inhibiting mTOR and activating Beclin-1 in thyroid cancer cells. (A) ARO, WRO, and TPC-1 cells were incubated with the indicated concentrations of FKB for 24 h. Levels of protein expression were analyzed by Western blot using antibodies against the indicated autophagy-related proteins and GAPDH. The number under each band represents the fold change of band intensity relative to control group. (B) WRO cells stably transfected with GFP-LC3B were further transfected with Beclin-1 siRNAs for 24 h, then treated with 6 μg/mL FKB for another 24 h. Cells were then examined by a fluorescence microscopy. Percentages of cells with more than four GFP-LC3B dots were quantified. (C) WRO cells were transfected with Beclin-1 siRNA or NC siRNA for 24 h, then treated with 6 μg/mL FKB for another 24 h. Levels of protein expression were analyzed by Western blot using antibodies against Beclin-1, LC3B, and GAPDH. All data are expressed as the mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 
| DISCUSSION
Multiple studies have provided compelling evidence that FKB, a novel chalcone isolated from kava root extracts, has anticancer effects in some aggressive malignancies. 5, 9, 10, 31 Inducing cell cycle arrest and inducing apoptosis were found to be the major mechanisms by which FKB induces cell death. We, for the first time,
showed that FKB induces autophagy in TCa cells.
Autophagy is one of the basic catabolic mechanisms to degrade and recycle damaged and dysfunctional organelles to mediate metabolic adaptation and maintain intracellular energy homeostasis, thus promoting the cellular survival response to nutrient starvation and stresses. 17 In the present study, we showed that FKB reduced ATP Autophagy is regulated by a complex signaling network, and compounds that trigger autophagy can be broadly classified into two groups: mTOR-dependent and mTOR-independent. Our results showed that FKB suppressed the level of p-mTOR, indicating that FKB induced mTOR-dependent autophagy in TCa cells. As a key upstream inhibitor of mTOR, AMPK acts as an important sensor of intracellular energy levels. 29 We found that FKB upregulated the level of p-AMPKαThr172, which in turn activated its substrates mTOR and Beclin-1. Furthermore, using RNA interference against AMPK or Beclin-1 and AMPK inhibitor Comp C in combination with FKB, we confirmed that the AMPK pathway is the crucial mediator of FKB-induced autophagy.
Autophagy plays two opposite roles of protector or inhibitor in tumor growth, which highly depends on cell types and inducers.
Some studies have shown that autophagy-inducing compounds have antiproliferative effects, 35, 36 whereas others induce protective autophagy, which antagonizes apoptotic cell death. [37] [38] [39] In this study, we
showed that inhibition of autophagy enhanced the cytotoxicity and 
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